US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mineralys Therapeutics, Inc.

14.66

-0.3400-2.27%

Post-market: 14.730.0700+0.48%17:59 EDT

Volume:1.69M

Turnover:24.56M

Market Cap:920.63M

PE:-4.00

High:15.06

Open:14.98

Low:14.11

Close:15.00

Loading ...

Overview Company News Filings

Mineralys Completes Enrollment in Mid-Stage Hypertension Trial

MT Newswires Live

Mineralys Therapeutics completes enrollment in Explore-CKD Phase 2 trial

Mineralys Therapeutics Inc - to Share Topline Data From Explore-Ckd Trial in Q2 2025

THOMSON REUTERS

Mineralys Therapeutics Completes Enrollment in Explore-Ckd Phase 2 Trial of Lorundrostat for the Treatment of Hypertension in Subjects With Stage 2 to 3B Ckd and Albuminuria

THOMSON REUTERS

Investors Await Key Inflation Data as US Futures Trend Higher Pre-Bell

MT Newswires Live

BRIEF-Mineralys Therapeutics Announces Mid-Stage Study Of Lorundrostat For Obstructive Sleep Apnea In Patients With Hypertension

Mineralys announces Phase 2 trial of lorundrostat in OSA

Mineralys Therapeutics Inc - Primary Outcome Measure Is Change in Apnea-Hypopnea Episodes

THOMSON REUTERS

Mineralys Therapeutics Inc - Expects Funds to Support Operations Through Q1 2026

THOMSON REUTERS

Mineralys Therapeutics Inc - to Initiate Phase 2 Trial in Q1 2025

THOMSON REUTERS

Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients With Hypertension

THOMSON REUTERS

Q3 2024 Mineralys Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents

Mineralys Therapeutics, Inc. (MLYS) Gets a Buy from Stifel Nicolaus

Mineralys Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary

Mineralys Therapeutics Q3 Net Loss Widens

MT Newswires Live

Mineralys Therapeutics Q3 2024 GAAP EPS $(1.13) Misses $(0.83) Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/MLYS/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MLYS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","market":"US","secType":"STK","nameCN":"Mineralys Therapeutics, Inc.","latestPrice":14.66,"timestamp":1743192000000,"preClose":15,"halted":0,"volume":1687595,"hourTrading":{"tag":"盘后","latestPrice":14.73,"preClose":14.66,"latestTime":"17:59 EDT","volume":200047,"amount":2932654.5065,"timestamp":1743199140542},"delay":0,"floatShares":40093900,"shares":62798600,"eps":-3.663179,"marketStatus":"Not Yet Opened","change":-0.34,"latestTime":"03-28 16:00:00 EDT","open":14.98,"high":15.0584,"low":14.11,"amount":24560353.07908,"amplitude":0.063227,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.663179,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1743408000000},"marketStatusCode":0,"adr":0,"listingDate":1676005200000,"exchange":"NASDAQ","adjPreClose":15,"preHourTrading":{"tag":"盘前","latestPrice":15.44,"preClose":15,"latestTime":"09:00 EDT","volume":279,"amount":4211.660124,"timestamp":1743166809334},"postHourTrading":{"tag":"盘后","latestPrice":14.73,"preClose":14.66,"latestTime":"17:59 EDT","volume":200047,"amount":2932654.5065,"timestamp":1743199140542},"volumeRatio":1.505514165165801,"impliedVol":0.9042,"impliedVolPercentile":0.636},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MLYS\",,,,,undefined,":{"symbol":"MLYS","floatShares":40093900,"roa":"-52.56%","roe":"-82.24%","lyrEps":-3.663179,"volumeRatio":1.505514165165801,"shares":62798600,"dividePrice":0,"high":15.0584,"amplitude":0.063227,"preClose":15,"low":14.11,"week52Low":8.241,"pbRate":"4.81","week52High":18.38,"institutionHeld":0,"latestPrice":14.66,"eps":-3.663179,"divideRate":0,"volume":1687595,"delay":0,"ttmEps":-3.663179,"open":14.98,"prevYearClose":12.31,"prevWeekClose":16.87,"prevMonthClose":9.14,"prevQuarterClose":12.31,"fiveDayClose":16.87,"twentyDayClose":9.14,"sixtyDayClose":12.52},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"MLYS\",pageSize:16,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2509466205","title":"Mineralys Completes Enrollment in Mid-Stage Hypertension Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2509466205","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509466205?lang=en_us&edition=fundamental","pubTime":"2025-02-05 00:20","pubTimestamp":1738686003,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics  said Tuesday it has completed enrollment in the phase 2 trial of lorundrostat for the treatment of hypertension in subjects with chronic kidney disease and albuminuria.The clinical-stage biopharmaceutical company said it continues to expect topline data from the trial in Q2 of 2025.Price: 9.92, Change: -0.01, Percent Change: -0.10","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MLYS","SSI","BK4139"],"gpt_icon":0},{"id":"2508596474","title":"Mineralys Therapeutics completes enrollment in Explore-CKD Phase 2 trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2508596474","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508596474?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:18","pubTimestamp":1738675106,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) has completed enrollment in the Explore-CKD Phase 2 trial evaluating the efficacy and safety of lorundrostat for the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-completes-enrollment-in-explore-ckd-phase-2-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mineralys-therapeutics-completes-enrollment-in-explore-ckd-phase-2-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS","LENZ","BK4139"],"gpt_icon":0},{"id":"2508456986","title":"Mineralys Therapeutics Inc - to Share Topline Data From Explore-Ckd Trial in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2508456986","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508456986?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:00","pubTimestamp":1738674001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250204:nTUA9JJBJF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2508456581","title":"Mineralys Therapeutics Completes Enrollment in Explore-Ckd Phase 2 Trial of Lorundrostat for the Treatment of Hypertension in Subjects With Stage 2 to 3B Ckd and Albuminuria","url":"https://stock-news.laohu8.com/highlight/detail?id=2508456581","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508456581?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:00","pubTimestamp":1738674001,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250204:nTUA9JJBJF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"gpt_icon":0},{"id":"2503520281","title":"Investors Await Key Inflation Data as US Futures Trend Higher Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2503520281","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503520281?lang=en_us&edition=fundamental","pubTime":"2025-01-14 21:17","pubTimestamp":1736860632,"startTime":"0","endTime":"0","summary":"US stock futures were tracking higher in Tuesday's premarket session as investors awaited key inflation data.Dow Jones Industrial Average futures were up 0.27%, S&P 500 futures were  0.30% higher, and","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"2191fbce08842cbd0fbb0560253b3fe0","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2023250843.SGD","BK4152","BK4516","BK4104","HEES","BK4588","BSBK","BK4130","BK4196","CCEL","ISBC","MLYS","BK4211","LU2023250504.SGD","BK4195","URI","BK4585","NMHI","STAF","BK4139","LU2106854487.HKD","LU1974910355.USD","LU1721428933.USD","LU1917777945.USD"],"gpt_icon":1},{"id":"2501205087","title":"BRIEF-Mineralys Therapeutics Announces Mid-Stage Study Of Lorundrostat For Obstructive Sleep Apnea In Patients With Hypertension","url":"https://stock-news.laohu8.com/highlight/detail?id=2501205087","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501205087?lang=en_us&edition=fundamental","pubTime":"2025-01-08 22:01","pubTimestamp":1736344911,"startTime":"0","endTime":"0","summary":"Jan 8  - Mineralys Therapeutics Inc   :   * MINERALYS THERAPEUTICS ANNOUNCES PHASE 2 CLINICAL TRIAL OF LORUNDROSTAT FOR OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH HYPERTENSION   * MINERALYS THERAPEUTICS INC - TO INITIATE PHASE 2 TRIAL IN Q1 2025   * MINERALYS THERAPEUTICS INC - EXPECTS FUNDS TO SUPPORT OPERATIONS THROUGH Q1 2026   * MINERALYS THERAPEUTICS INC - PRIMARY OUTCOME MEASURE IS CHANGE IN APNEA-HYPOPNEA EPISODESSource text:   Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","LENZ","SSI","BK4139"],"gpt_icon":0},{"id":"2501724763","title":"Mineralys announces Phase 2 trial of lorundrostat in OSA","url":"https://stock-news.laohu8.com/highlight/detail?id=2501724763","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501724763?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:15","pubTimestamp":1736342126,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) announced that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug (IND) Applica...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mineralys-announces-phase-2-trial-of-lorundrostat-in-osa?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mineralys-announces-phase-2-trial-of-lorundrostat-in-osa?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2501721991","title":"Mineralys Therapeutics Inc - Primary Outcome Measure Is Change in Apnea-Hypopnea Episodes","url":"https://stock-news.laohu8.com/highlight/detail?id=2501721991","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501721991?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341208,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUAX3KQZ:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"gpt_icon":0},{"id":"2501721937","title":"Mineralys Therapeutics Inc - Expects Funds to Support Operations Through Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2501721937","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501721937?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341208,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUAX3KQZ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MLYS","BK4139"],"gpt_icon":0},{"id":"2501721512","title":"Mineralys Therapeutics Inc - to Initiate Phase 2 Trial in Q1 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2501721512","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501721512?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341208,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUAX3KQZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"gpt_icon":0},{"id":"2501072152","title":"Mineralys Therapeutics Announces Phase 2 Clinical Trial of Lorundrostat for Obstructive Sleep Apnea in Patients With Hypertension","url":"https://stock-news.laohu8.com/highlight/detail?id=2501072152","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501072152?lang=en_us&edition=fundamental","pubTime":"2025-01-08 21:00","pubTimestamp":1736341208,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250108:nTUAX3KQZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","MLYS"],"gpt_icon":0},{"id":"2482808467","title":"Q3 2024 Mineralys Therapeutics Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2482808467","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482808467?lang=en_us&edition=fundamental","pubTime":"2024-11-12 23:12","pubTimestamp":1731424374,"startTime":"0","endTime":"0","summary":"Jon Congleton; Chief Executive Officer, Director; Mineralys Therapeutics Inc. Adam Levy; Chief Financial Officer, Company Secretary; Mineralys Therapeutics Inc. David Rodman; Chief Medical Officer; Mineralys Therapeutics Inc. Thank you, Dan. Good afternoon, everyone, and welcome to our third-quarter 2024 financial-results and corporate update conference call. I'm joined today by Adam Levy, our Chief Financial Officer; and Dr. David Rodman, our Chief Medical Officer. I'll begin with an overview of the business, our clinical programs and recent milestones. Then Adam will review our third quarter financial results before we open up the call for your questions. I want to kick things off with a recap of the progress the Mineralys team has made these past several months, advancing our pivotal clinical development of lorundrostat in hypertension and then discuss the upcoming milestones we anticipate throughout the first half of 2025. We recently completed enrollment in our pivotal Advance-HTN","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q3-2024-mineralys-therapeutics-inc-151254278.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MLYS","LENZ"],"gpt_icon":0},{"id":"2482088221","title":"Mineralys Therapeutics, Inc. (MLYS) Gets a Buy from Stifel Nicolaus","url":"https://stock-news.laohu8.com/highlight/detail?id=2482088221","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482088221?lang=en_us&edition=fundamental","pubTime":"2024-11-12 22:15","pubTimestamp":1731420957,"startTime":"0","endTime":"0","summary":"Stifel Nicolaus analyst Annabel Samimy reiterated a Buy rating on Mineralys Therapeutics, Inc. (MLYS – Research Report) today and set a price targe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mineralys-therapeutics-inc-mlys-gets-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mineralys-therapeutics-inc-mlys-gets-a-buy-from-stifel-nicolaus?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SF","MLYS","BK4127","BK4139"],"gpt_icon":0},{"id":"2482714569","title":"Mineralys Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2482714569","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482714569?lang=en_us&edition=fundamental","pubTime":"2024-11-12 11:43","pubTimestamp":1731382994,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics Inc reports results for the quarter ended September 30 - Earnings SummaryMineralys Therapeutics Inc MLYS.OQ reported a quarterly adjusted loss of $1.13 per share for the quarter","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nL8N3MJ04L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS"],"gpt_icon":0},{"id":"2482761328","title":"Mineralys Therapeutics Q3 Net Loss Widens","url":"https://stock-news.laohu8.com/highlight/detail?id=2482761328","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482761328?lang=en_us&edition=fundamental","pubTime":"2024-11-12 05:56","pubTimestamp":1731362200,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics  reported a Q3 net loss late Monday of $1.13 per diluted share, widening from $0.57 a year earlier.Analysts polled by Capital IQ expected a loss of $0.83.Cash, cash equivalents and investments as of Sept. 30 were $263.6 million, up from $239 million as of Dec. 31, 2023.Mineralys said it expects current cash, cash equivalents and investments to fund clinical trials and corporate operations into 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","MLYS","BK4139"],"gpt_icon":0},{"id":"2482765525","title":"Mineralys Therapeutics Q3 2024 GAAP EPS $(1.13) Misses $(0.83) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2482765525","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482765525?lang=en_us&edition=fundamental","pubTime":"2024-11-12 05:07","pubTimestamp":1731359231,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (NASDAQ:MLYS) reported quarterly losses of $(1.13) per share which missed the analyst consensus estimate of $(0.83) by 36.14 percent.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41887840/mineralys-therapeutics-q3-2024-gaap-eps-1-13-misses-0-83-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MLYS","LENZ"],"gpt_icon":0}],"pageSize":16,"totalPage":5,"pageCount":4,"totalSize":73}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MLYS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-02-12","symbol":"MLYS","fiscalQuarterEnding":"2024/12","expectedEps":1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1739336400000,"reportTimeType":"pre","actualEps":-0.98},{"market":"US","date":"2024-11-11","symbol":"MLYS","fiscalQuarterEnding":"2024/09","expectedEps":-0.83,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731301200000,"reportTimeType":"post","actualEps":-1.13},{"market":"US","date":"2024-08-13","symbol":"MLYS","fiscalQuarterEnding":"2024/06","expectedEps":-0.73,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"post","actualEps":-0.83},{"market":"US","date":"2024-05-09","symbol":"MLYS","fiscalQuarterEnding":"2024/03","expectedEps":-0.68,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":-0.7},{"market":"US","date":"2024-03-21","symbol":"MLYS","fiscalQuarterEnding":"2023/12","expectedEps":-0.85,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1710993600000,"reportTimeType":"pre","actualEps":-0.61}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MLYS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MLYS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.375,"buy":0.625,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1741924800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MLYS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MLYS","date":"2025-03-28","current":-4.20412,"percent":0.842829,"low":-28.120261,"twenty":-17.509324,"median":-7.643917,"eighty":-4.682096,"high":-2.455206,"avg":-10.070543,"sd":6.45138,"marketCap":747534555},"quantilePoints":[{"date":"2023-02-10","current":-25.898259,"twenty":-24.067223,"median":-21.320668,"eighty":-10.744265,"marketCap":720204681},{"date":"2023-02-17","current":-26.342543,"twenty":-26.413064,"median":-26.058397,"eighty":-23.151704,"marketCap":732559788},{"date":"2023-02-24","current":-26.298468,"twenty":-26.483585,"median":-26.320505,"eighty":-25.926348,"marketCap":731334088},{"date":"2023-03-03","current":-28.120261,"twenty":-26.483585,"median":-26.122165,"eighty":-25.407434,"marketCap":781996338},{"date":"2023-03-10","current":-23.918383,"twenty":-26.483585,"median":-26.166241,"eighty":-25.1907,"marketCap":665146310},{"date":"2023-03-17","current":-21.169392,"twenty":-26.45714,"median":-26.078089,"eighty":-23.824355,"marketCap":630826722},{"date":"2023-03-24","current":-20.744359,"twenty":-26.427757,"median":-25.591493,"eighty":-21.169392,"marketCap":618161159},{"date":"2023-03-31","current":-21.471029,"twenty":-26.354297,"median":-24.873355,"eighty":-21.103581,"marketCap":639815185},{"date":"2023-04-06","current":-19.11278,"twenty":-26.342543,"median":-23.918383,"eighty":-20.744359,"marketCap":569541742},{"date":"2023-04-14","current":-18.427243,"twenty":-26.298468,"median":-22.156566,"eighty":-20.113665,"marketCap":549113416},{"date":"2023-04-21","current":-18.879698,"twenty":-26.210316,"median":-21.471029,"eighty":-19.688632,"marketCap":562596111},{"date":"2023-04-28","current":-17.933656,"twenty":-26.122165,"median":-21.24503,"eighty":-18.783722,"marketCap":534405021},{"date":"2023-05-05","current":-20.086243,"twenty":-26.092781,"median":-21.087128,"eighty":-18.674036,"marketCap":598549966},{"date":"2023-05-12","current":-21.992037,"twenty":-26.078089,"median":-21.24503,"eighty":-18.728879,"marketCap":655340714},{"date":"2023-05-19","current":-21.745244,"twenty":-26.038705,"median":-21.457318,"eighty":-18.783722,"marketCap":647986516},{"date":"2023-05-26","current":-16.559387,"twenty":-25.898259,"median":-21.176247,"eighty":-18.591772,"marketCap":576895940},{"date":"2023-06-02","current":-16.969854,"twenty":-25.407434,"median":-21.12826,"eighty":-18.572577,"marketCap":591195768},{"date":"2023-06-09","current":-17.990156,"twenty":-25.1907,"median":-20.744359,"eighty":-18.397637,"marketCap":626741057},{"date":"2023-06-16","current":-18.271619,"twenty":-24.932123,"median":-20.360458,"eighty":-18.2552,"marketCap":636546653},{"date":"2023-06-23","current":-18.869727,"twenty":-24.820464,"median":-20.099954,"eighty":-18.341985,"marketCap":657383546},{"date":"2023-06-30","current":-19.432652,"twenty":-24.438476,"median":-19.960543,"eighty":-18.318529,"marketCap":676994740},{"date":"2023-07-07","current":-18.177798,"twenty":-23.894876,"median":-19.784607,"eighty":-18.295074,"marketCap":633278121},{"date":"2023-07-14","current":-18.224708,"twenty":-23.631036,"median":-19.510392,"eighty":-18.189525,"marketCap":634912387},{"date":"2023-07-21","current":-17.403775,"twenty":-22.844845,"median":-19.344695,"eighty":-18.039908,"marketCap":606312730},{"date":"2023-07-28","current":-16.395201,"twenty":-22.373196,"median":-18.879698,"eighty":-17.903799,"marketCap":571176008},{"date":"2023-08-04","current":-15.996462,"twenty":-22.189472,"median":-18.77395,"eighty":-17.722767,"marketCap":557284746},{"date":"2023-08-11","current":-13.235538,"twenty":-22.153824,"median":-18.728996,"eighty":-17.560925,"marketCap":536039287},{"date":"2023-08-18","current":-12.28726,"twenty":-22.129144,"median":-18.70554,"eighty":-17.406121,"marketCap":497634033},{"date":"2023-08-25","current":-13.043865,"twenty":-22.057849,"median":-18.632904,"eighty":-17.159841,"marketCap":528276523},{"date":"2023-09-01","current":-12.953072,"twenty":-21.986553,"median":-18.590018,"eighty":-16.81974,"marketCap":524599424},{"date":"2023-09-08","current":-11.823209,"twenty":-21.9701,"median":-18.578061,"eighty":-16.550005,"marketCap":478839973},{"date":"2023-09-15","current":-12.055235,"twenty":-21.909773,"median":-18.516678,"eighty":-16.005844,"marketCap":488237003},{"date":"2023-09-21","current":-10.249471,"twenty":-21.805571,"median":-18.455971,"eighty":-13.439317,"marketCap":415103594},{"date":"2023-09-29","current":-9.381898,"twenty":-21.588941,"median":-18.399822,"eighty":-13.144746,"marketCap":379966872},{"date":"2023-10-06","current":-9.926653,"twenty":-21.476513,"median":-18.254027,"eighty":-13.011583,"marketCap":402029465},{"date":"2023-10-13","current":-8.655558,"twenty":-21.471029,"median":-18.201253,"eighty":-12.658501,"marketCap":350550082},{"date":"2023-10-20","current":-8.221771,"twenty":-21.462802,"median":-18.183661,"eighty":-12.299366,"marketCap":332981721},{"date":"2023-10-27","current":-8.12089,"twenty":-21.457318,"median":-18.137991,"eighty":-12.28726,"marketCap":328896056},{"date":"2023-11-03","current":-7.868689,"twenty":-21.320668,"median":-17.990156,"eighty":-12.105675,"marketCap":318681893},{"date":"2023-11-10","current":-5.375877,"twenty":-21.183103,"median":-17.914995,"eighty":-11.823209,"marketCap":304177873},{"date":"2023-11-17","current":-4.874613,"twenty":-21.169392,"median":-17.861152,"eighty":-10.774051,"marketCap":275815341},{"date":"2023-11-24","current":-4.554966,"twenty":-21.169392,"median":-17.720421,"eighty":-10.138503,"marketCap":257729089},{"date":"2023-12-01","current":-4.838289,"twenty":-21.103581,"median":-17.57969,"eighty":-9.743051,"marketCap":273760085},{"date":"2023-12-08","current":-5.012642,"twenty":-21.06519,"median":-17.497596,"eighty":-9.458568,"marketCap":283625314},{"date":"2023-12-15","current":-5.993376,"twenty":-20.807428,"median":-17.409639,"eighty":-9.291106,"marketCap":339117223},{"date":"2023-12-22","current":-5.42673,"twenty":-20.459176,"median":-17.321682,"eighty":-8.792756,"marketCap":307055231},{"date":"2023-12-29","current":-6.225847,"twenty":-20.376911,"median":-17.198542,"eighty":-8.403356,"marketCap":352270861},{"date":"2024-01-05","current":-6.269435,"twenty":-20.360458,"median":-17.051947,"eighty":-8.171331,"marketCap":354737168},{"date":"2024-01-12","current":-6.552758,"twenty":-20.360458,"median":-16.876033,"eighty":-7.818248,"marketCap":370768164},{"date":"2024-01-19","current":-6.007906,"twenty":-20.163024,"median":-16.565251,"eighty":-6.745999,"marketCap":339939325},{"date":"2024-01-26","current":-7.729639,"twenty":-20.091727,"median":-16.395201,"eighty":-6.689335,"marketCap":437358455},{"date":"2024-02-02","current":-9.226167,"twenty":-20.060621,"median":-16.002326,"eighty":-6.745999,"marketCap":522034998},{"date":"2024-02-09","current":-10.192372,"twenty":-19.90434,"median":-13.48774,"eighty":-6.843346,"marketCap":576704805},{"date":"2024-02-16","current":-13.090301,"twenty":-19.80106,"median":-13.291023,"eighty":-7.190598,"marketCap":740675419},{"date":"2024-02-23","current":-13.68452,"twenty":-19.784607,"median":-13.356595,"eighty":-7.398369,"marketCap":774297534},{"date":"2024-03-01","current":-13.439842,"twenty":-19.727022,"median":-13.369934,"eighty":-7.593212,"marketCap":760453134},{"date":"2024-03-08","current":-12.216449,"twenty":-19.581688,"median":-13.356595,"eighty":-7.704554,"marketCap":691231132},{"date":"2024-03-15","current":-11.010534,"twenty":-19.485713,"median":-13.235538,"eighty":-7.770699,"marketCap":622998016},{"date":"2024-03-22","current":-9.036021,"twenty":-19.447295,"median":-13.106761,"eighty":-7.810178,"marketCap":649671871},{"date":"2024-03-28","current":-8.822029,"twenty":-19.362286,"median":-13.087259,"eighty":-7.838424,"marketCap":634286212},{"date":"2024-04-05","current":-8.704678,"twenty":-19.199155,"median":-13.043865,"eighty":-7.874093,"marketCap":625848914},{"date":"2024-04-12","current":-9.049827,"twenty":-19.019547,"median":-12.93794,"eighty":-7.899633,"marketCap":650664494},{"date":"2024-04-19","current":-7.42072,"twenty":-18.87571,"median":-12.8631,"eighty":-7.899633,"marketCap":533534959},{"date":"2024-04-26","current":-7.620907,"twenty":-18.835325,"median":-12.698294,"eighty":-7.82767,"marketCap":547927995},{"date":"2024-05-03","current":-9.036021,"twenty":-18.775904,"median":-12.579814,"eighty":-7.852557,"marketCap":649671871},{"date":"2024-05-10","current":-7.800135,"twenty":-18.750105,"median":-12.324461,"eighty":-7.852557,"marketCap":708236638},{"date":"2024-05-17","current":-7.190448,"twenty":-18.728996,"median":-12.28726,"eighty":-7.795318,"marketCap":652878301},{"date":"2024-05-24","current":-6.68739,"twenty":-18.728949,"median":-12.230329,"eighty":-7.639315,"marketCap":607201644},{"date":"2024-05-31","current":-6.791282,"twenty":-18.724211,"median":-12.17115,"eighty":-7.398356,"marketCap":616634866},{"date":"2024-06-07","current":-7.354489,"twenty":-18.70554,"median":-12.105675,"eighty":-7.206751,"marketCap":667772863},{"date":"2024-06-14","current":-6.938919,"twenty":-18.70554,"median":-12.055235,"eighty":-7.152172,"marketCap":630039972},{"date":"2024-06-21","current":-6.403053,"twenty":-18.680337,"median":-11.823209,"eighty":-7.108428,"marketCap":581384403},{"date":"2024-06-28","current":-6.288225,"twenty":-18.66581,"median":-11.779523,"eighty":-7.077807,"marketCap":570958210},{"date":"2024-07-05","current":-6.643646,"twenty":-18.632904,"median":-11.587276,"eighty":-6.982663,"marketCap":603229761},{"date":"2024-07-12","current":-7.420105,"twenty":-18.591772,"median":-11.06276,"eighty":-6.938919,"marketCap":673730687},{"date":"2024-07-15","current":-7.917695,"twenty":-18.591772,"median":-11.03634,"eighty":-6.947668,"marketCap":718910859},{"date":"2024-08-02","current":-6.588966,"twenty":-18.591772,"median":-11.027806,"eighty":-6.909392,"marketCap":598264907},{"date":"2024-08-09","current":-6.10778,"twenty":-18.590369,"median":-11.001795,"eighty":-6.863476,"marketCap":554574191},{"date":"2024-08-16","current":-4.055555,"twenty":-18.584183,"median":-10.737476,"eighty":-6.770215,"marketCap":485332348},{"date":"2024-08-23","current":-4.683003,"twenty":-18.568069,"median":-10.249471,"eighty":-6.677548,"marketCap":560419627},{"date":"2024-08-30","current":-5.223189,"twenty":-18.552105,"median":-10.150916,"eighty":-6.645833,"marketCap":625064304},{"date":"2024-09-06","current":-4.961407,"twenty":-18.537055,"median":-9.931698,"eighty":-6.596254,"marketCap":593736499},{"date":"2024-09-13","current":-4.815972,"twenty":-18.48037,"median":-9.781545,"eighty":-6.475316,"marketCap":576332163},{"date":"2024-09-20","current":-5.027891,"twenty":-18.464981,"median":-9.603836,"eighty":-6.37643,"marketCap":601692767},{"date":"2024-09-27","current":-4.982183,"twenty":-18.438212,"median":-9.472691,"eighty":-6.291732,"marketCap":596222833},{"date":"2024-10-04","current":-5.364469,"twenty":-18.421759,"median":-9.412162,"eighty":-6.214223,"marketCap":641971374},{"date":"2024-10-11","current":-5.576388,"twenty":-18.397637,"median":-9.311282,"eighty":-6.10778,"marketCap":667331978},{"date":"2024-10-18","current":-5.767531,"twenty":-18.36544,"median":-9.209355,"eighty":-5.996282,"marketCap":690206249},{"date":"2024-10-25","current":-5.651183,"twenty":-18.264582,"median":-9.139785,"eighty":-5.887312,"marketCap":676282780},{"date":"2024-10-31","current":-5.725979,"twenty":-18.236436,"median":-9.059079,"eighty":-5.811759,"marketCap":685233581},{"date":"2024-11-08","current":-5.883879,"twenty":-18.224708,"median":-9.036021,"eighty":-5.796618,"marketCap":704129718},{"date":"2024-11-15","current":-3.952188,"twenty":-18.201253,"median":-8.994603,"eighty":-5.767531,"marketCap":605684701},{"date":"2024-11-22","current":-3.854764,"twenty":-18.189525,"median":-8.953186,"eighty":-5.710053,"marketCap":590754101},{"date":"2024-11-29","current":-4.147037,"twenty":-18.189525,"median":-8.91986,"eighty":-5.679439,"marketCap":635545903},{"date":"2024-12-06","current":-3.968426,"twenty":-18.180143,"median":-8.904865,"eighty":-5.650352,"marketCap":608173135},{"date":"2024-12-13","current":-3.952188,"twenty":-18.114108,"median":-8.863447,"eighty":-5.605476,"marketCap":605684701},{"date":"2024-12-20","current":-3.841774,"twenty":-18.039908,"median":-8.833874,"eighty":-5.416559,"marketCap":588763354},{"date":"2024-12-27","current":-4.179512,"twenty":-18.004229,"median":-8.822029,"eighty":-5.28349,"marketCap":640522770},{"date":"2025-01-03","current":-3.978168,"twenty":-17.971392,"median":-8.704678,"eighty":-5.202978,"marketCap":609666195},{"date":"2025-01-10","current":-3.637182,"twenty":-17.941328,"median":-8.655558,"eighty":-5.112283,"marketCap":557409092},{"date":"2025-01-17","current":-3.08511,"twenty":-17.926192,"median":-8.487234,"eighty":-5.032877,"marketCap":472802355},{"date":"2025-01-24","current":-3.331919,"twenty":-17.896335,"median":-8.4084,"eighty":-5.007115,"marketCap":510626543},{"date":"2025-01-31","current":-3.335166,"twenty":-17.884608,"median":-8.283595,"eighty":-4.965562,"marketCap":511124230},{"date":"2025-02-07","current":-3.263722,"twenty":-17.861152,"median":-8.182593,"eighty":-4.939995,"marketCap":500175123},{"date":"2025-02-14","current":-2.858802,"twenty":-17.732149,"median":-8.12089,"eighty":-4.915699,"marketCap":508323497},{"date":"2025-02-21","current":-2.671017,"twenty":-17.722767,"median":-7.925786,"eighty":-4.894448,"marketCap":474933620},{"date":"2025-02-28","current":-2.791536,"twenty":-17.6497,"median":-7.886161,"eighty":-4.860849,"marketCap":496362944},{"date":"2025-03-07","current":-2.954095,"twenty":-17.590156,"median":-7.841803,"eighty":-4.835603,"marketCap":525267613},{"date":"2025-03-14","current":-3.783708,"twenty":-17.57969,"median":-7.799104,"eighty":-4.804337,"marketCap":672781099},{"date":"2025-03-21","current":-4.688995,"twenty":-17.560925,"median":-7.729639,"eighty":-4.688342,"marketCap":833750207},{"date":"2025-03-28","current":-4.20412,"twenty":-17.509324,"median":-7.643917,"eighty":-4.682096,"marketCap":747534555}],"updateTime":1743395592559}}}